Prasad S. Adusumilli

Prasad S. Adusumilli is a Professor of Surgery at Weill Cornell Medicine and an Attending Surgeon at Memorial Sloan Kettering Cancer Center (MSKCC), specializing in thoracic oncology. He serves as Associate Editor for Cancer Immunity and Immunotherapy at Frontiers in Immunology and contributes to editorial boards for Frontiers in Oncology.

His research centers on translational immunotherapy for thoracic malignancies, with emphasis on CAR T-cell engineering for mesothelioma and lung cancer. Key interests include targeting complement system proteins (e.g., gC1qR/p32), optimizing trimodality therapy (surgery/radiation/chemotherapy), and developing biomarkers for treatment response. His work bridges molecular discovery to clinical application through extensive collaboration with MSKCC surgical and medical oncology teams.

Analysis of his 2017–2020 publications reveals a cohesive focus on overcoming immunosuppressive tumor microenvironments in mesothelioma. Trends include validation of novel therapeutic targets, refinement of patient selection criteria for complex therapies, and leadership in consensus guidelines for multimodal management. Disciplinary intersections span surgical oncology, molecular immunology, and radiation biology.

Dr. Adusumilli maintains an active research network with 12 professional connections, including MSKCC colleagues in thoracic surgery (e.g., Valerie W. Rusch) and oncology. His collaborations drive high-impact publications in Journal of Thoracic Oncology and Frontiers journals, reflecting leadership in advancing cellular therapies for solid tumors.